APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antivirals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antivirals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchAntivirals Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antivirals Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Antivirals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antivirals Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antivirals Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Antivirals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antivirals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antivirals include Teva Pharmaceutical Industries, Johnson & Johnson, Merck, Mylan, Gilead Sciences, GSK, AbbVie, F. Hoffmann-La Roche and Dr Reddy’s, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antivirals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antivirals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antivirals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antivirals market size, projected growth trends, production technologies, key applications, and end-use industries.

Antivirals Segment by Company

Teva Pharmaceutical Industries

Johnson & Johnson

Merck

Mylan

Gilead Sciences

GSK

AbbVie

F. Hoffmann-La Roche

Dr Reddy’s

Cipla

Bristol-Myers-Squibb

Aurobindo Pharma

Antivirals Segment by Type

Generic

Branded

Antivirals Segment by Application

HIV

Influenza

Hepatitis

HSV

Antivirals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antivirals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antivirals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antivirals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antivirals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antivirals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antivirals Industry Trends Table 2. Antivirals Industry Drivers Table 3. Antivirals Industry Opportunities and Challenges Table 4. Antivirals Industry Restraints Table 5. Global Antivirals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antivirals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antivirals Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Antivirals Sales Market Share by Manufacturers Table 9. Global Antivirals Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Antivirals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antivirals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antivirals Manufacturers, Product Type & Application Table 13. Global Antivirals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antivirals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Generic Table 17. Major Manufacturers of Branded Table 18. Global Antivirals Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 19. Global Antivirals Sales by Type (2021-2026) & (k tons) Table 20. Global Antivirals Sales by Type (2027-2032) & (k tons) Table 21. Global Antivirals Sales Market Share by Type (2021-2026) Table 22. Global Antivirals Sales Market Share by Type (2027-2032) Table 23. Global Antivirals Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 24. Global Antivirals Revenue by Type (2021-2026) & (k tons) Table 25. Global Antivirals Revenue by Type (2027-2032) & (k tons) Table 26. Global Antivirals Revenue Market Share by Type (2021-2026) Table 27. Global Antivirals Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of HIV Table 29. Major Manufacturers of Influenza Table 30. Major Manufacturers of Hepatitis Table 31. Major Manufacturers of HSV Table 32. Global Antivirals Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global Antivirals Sales by Application (2021-2026) & (k tons) Table 34. Global Antivirals Sales by Application (2027-2032) & (k tons) Table 35. Global Antivirals Sales Market Share by Application (2021-2026) Table 36. Global Antivirals Sales Market Share by Application (2027-2032) Table 37. Global Antivirals Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 38. Global Antivirals Revenue by Application (2021-2026) & (k tons) Table 39. Global Antivirals Revenue by Application (2027-2032) & (k tons) Table 40. Global Antivirals Revenue Market Share by Application (2021-2026) Table 41. Global Antivirals Revenue Market Share by Application (2027-2032) Table 42. Global Antivirals Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global Antivirals Sales by Region (2021-2026) & (k tons) Table 44. Global Antivirals Sales Market Share by Region (2021-2026) Table 45. Global Antivirals Sales Forecasted by Region (2027-2032) & (k tons) Table 46. Global Antivirals Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 48. North America Antivirals Sales by Country (2021-2026) & (k tons) Table 49. North America Antivirals Sales by Country (2027-2032) & (k tons) Table 50. Europe Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. Europe Antivirals Sales by Country (2021-2026) & (k tons) Table 52. Europe Antivirals Sales by Country (2027-2032) & (k tons) Table 53. Asia Pacific Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Asia Pacific Antivirals Sales by Country (2021-2026) & (k tons) Table 55. Asia Pacific Antivirals Sales by Country (2027-2032) & (k tons) Table 56. South America, Middle East and Africa Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. South America, Middle East and Africa Antivirals Sales by Country (2021-2026) & (k tons) Table 58. South America, Middle East and Africa Antivirals Sales by Country (2027-2032) & (k tons) Table 59. Global Antivirals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Antivirals Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Antivirals Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Antivirals Revenue Market Share by Region (2021-2026) Table 63. Global Antivirals Revenue Market Share by Region (2027-2032) Table 64. Teva Pharmaceutical Industries Company Information Table 65. Teva Pharmaceutical Industries Business Overview Table 66. Teva Pharmaceutical Industries Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Antivirals Product Portfolio Table 68. Teva Pharmaceutical Industries Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Antivirals Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Antivirals Product Portfolio Table 78. Merck Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Antivirals Product Portfolio Table 83. Mylan Recent Development Table 84. Gilead Sciences Company Information Table 85. Gilead Sciences Business Overview Table 86. Gilead Sciences Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Gilead Sciences Antivirals Product Portfolio Table 88. Gilead Sciences Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GSK Antivirals Product Portfolio Table 93. GSK Recent Development Table 94. AbbVie Company Information Table 95. AbbVie Business Overview Table 96. AbbVie Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. AbbVie Antivirals Product Portfolio Table 98. AbbVie Recent Development Table 99. F. Hoffmann-La Roche Company Information Table 100. F. Hoffmann-La Roche Business Overview Table 101. F. Hoffmann-La Roche Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. F. Hoffmann-La Roche Antivirals Product Portfolio Table 103. F. Hoffmann-La Roche Recent Development Table 104. Dr Reddy’s Company Information Table 105. Dr Reddy’s Business Overview Table 106. Dr Reddy’s Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Dr Reddy’s Antivirals Product Portfolio Table 108. Dr Reddy’s Recent Development Table 109. Cipla Company Information Table 110. Cipla Business Overview Table 111. Cipla Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Cipla Antivirals Product Portfolio Table 113. Cipla Recent Development Table 114. Bristol-Myers-Squibb Company Information Table 115. Bristol-Myers-Squibb Business Overview Table 116. Bristol-Myers-Squibb Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Bristol-Myers-Squibb Antivirals Product Portfolio Table 118. Bristol-Myers-Squibb Recent Development Table 119. Aurobindo Pharma Company Information Table 120. Aurobindo Pharma Business Overview Table 121. Aurobindo Pharma Antivirals Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Aurobindo Pharma Antivirals Product Portfolio Table 123. Aurobindo Pharma Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Antivirals Distributors List Table 127. Antivirals Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Antivirals Product Image Figure 2. Global Antivirals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antivirals Market Size (2021-2032) & (US$ Million) Figure 4. Global Antivirals Sales (2021-2032) & (k tons) Figure 5. Global Antivirals Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Antivirals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Generic Image Figure 9. Branded Image Figure 10. Global Antivirals Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 11. Global Antivirals Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Antivirals Sales Market Share by Type (2021-2032) Figure 13. Global Antivirals Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Antivirals Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Antivirals Revenue Market Share by Type (2021-2032) Figure 16. HIV Image Figure 17. Influenza Image Figure 18. Hepatitis Image Figure 19. HSV Image Figure 20. Global Antivirals Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global Antivirals Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Antivirals Sales Market Share by Application (2021-2032) Figure 23. Global Antivirals Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Antivirals Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Antivirals Revenue Market Share by Application (2021-2032) Figure 26. North America Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 27. North America Antivirals Sales Market Share by Country (2021-2032) Figure 28. U.S. Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Canada Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Mexico Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe Antivirals Sales Market Share by Country (2021-2032) Figure 33. Germany Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 34. France Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 35. U.K. Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Italy Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Netherlands Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific Antivirals Sales Market Share by Country (2021-2032) Figure 40. China Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Japan Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 42. South Korea Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Southeast Asia Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 44. India Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Australia Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa Antivirals Sales Market Share by Country (2021-2032) Figure 48. Brazil Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South Africa Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Saudi Arabia Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Turkey Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Argentina Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 53. UAE Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Egypt Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Chile Antivirals Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Global Antivirals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Antivirals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Antivirals Revenue (2021-2032) & (US$ Million) Figure 59. North America Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Antivirals Revenue (2021-2032) & (US$ Million) Figure 61. Europe Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Antivirals Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Antivirals Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Antivirals Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antivirals Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Generic
  • Branded
Applications
  • HIV
  • Influenza
  • Hepatitis
  • HSV
Companies covered
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Merck
  • Mylan
  • Gilead Sciences
  • GSK
  • AbbVie
  • F. Hoffmann-La Roche
  • Dr Reddy’s
  • Cipla
  • Bristol-Myers-Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antivirals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antivirals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antivirals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antivirals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antivirals Market Dynamics
  1. 2.1 Antivirals Industry Trends
  2. 2.2 Antivirals Industry Drivers
  3. 2.3 Antivirals Industry Opportunities and Challenges
  4. 2.4 Antivirals Industry Restraints
3 Antivirals Market by Manufacturers
  1. 3.1 Global Antivirals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antivirals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antivirals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antivirals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antivirals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antivirals Manufacturers, Product Type & Application
  7. 3.7 Global Antivirals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antivirals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antivirals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antivirals Tier 1, Tier 2, and Tier 3
4 Antivirals Market by Type
  1. 4.1 Antivirals Type Introduction
  2. 4.1.1 Generic
  3. 4.1.2 Branded
  4. 4.2 Global Antivirals Sales by Type
  5. 4.2.1 Global Antivirals Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antivirals Sales by Type (2021-2032)
  7. 4.2.3 Global Antivirals Sales Market Share by Type (2021-2032)
  8. 4.3 Global Antivirals Revenue by Type
  9. 4.3.1 Global Antivirals Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Antivirals Revenue by Type (2021-2032)
  11. 4.3.3 Global Antivirals Revenue Market Share by Type (2021-2032)
5 Antivirals Market by Application
  1. 5.1 Antivirals Application Introduction
  2. 5.1.1 HIV
  3. 5.1.2 Influenza
  4. 5.1.3 Hepatitis
  5. 5.1.4 HSV
  6. 5.2 Global Antivirals Sales by Application
  7. 5.2.1 Global Antivirals Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antivirals Sales by Application (2021-2032)
  9. 5.2.3 Global Antivirals Sales Market Share by Application (2021-2032)
  10. 5.3 Global Antivirals Revenue by Application
  11. 5.3.1 Global Antivirals Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antivirals Revenue by Application (2021-2032)
  13. 5.3.3 Global Antivirals Revenue Market Share by Application (2021-2032)
6 Global Antivirals Sales by Region
  1. 6.1 Global Antivirals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antivirals Sales by Region (2021-2032)
  3. 6.2.1 Global Antivirals Sales by Region (2021-2026)
  4. 6.2.2 Global Antivirals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antivirals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antivirals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antivirals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antivirals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antivirals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antivirals Revenue by Region
  1. 7.1 Global Antivirals Revenue by Region
  2. 7.1.1 Global Antivirals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antivirals Revenue by Region (2021-2026)
  4. 7.1.3 Global Antivirals Revenue by Region (2027-2032)
  5. 7.1.4 Global Antivirals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antivirals Revenue (2021-2032)
  8. 7.2.2 North America Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antivirals Revenue (2021-2032)
  11. 7.3.2 Europe Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antivirals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antivirals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antivirals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Antivirals Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Antivirals Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Antivirals Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Antivirals Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Gilead Sciences
  26. 8.5.1 Gilead Sciences Company Information
  27. 8.5.2 Gilead Sciences Business Overview
  28. 8.5.3 Gilead Sciences Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gilead Sciences Antivirals Product Portfolio
  30. 8.5.5 Gilead Sciences Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Antivirals Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 AbbVie
  38. 8.7.1 AbbVie Company Information
  39. 8.7.2 AbbVie Business Overview
  40. 8.7.3 AbbVie Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Antivirals Product Portfolio
  42. 8.7.5 AbbVie Recent Developments
  43. 8.8 F. Hoffmann-La Roche
  44. 8.8.1 F. Hoffmann-La Roche Company Information
  45. 8.8.2 F. Hoffmann-La Roche Business Overview
  46. 8.8.3 F. Hoffmann-La Roche Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 F. Hoffmann-La Roche Antivirals Product Portfolio
  48. 8.8.5 F. Hoffmann-La Roche Recent Developments
  49. 8.9 Dr Reddy’s
  50. 8.9.1 Dr Reddy’s Company Information
  51. 8.9.2 Dr Reddy’s Business Overview
  52. 8.9.3 Dr Reddy’s Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr Reddy’s Antivirals Product Portfolio
  54. 8.9.5 Dr Reddy’s Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Antivirals Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 Bristol-Myers-Squibb
  62. 8.11.1 Bristol-Myers-Squibb Company Information
  63. 8.11.2 Bristol-Myers-Squibb Business Overview
  64. 8.11.3 Bristol-Myers-Squibb Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bristol-Myers-Squibb Antivirals Product Portfolio
  66. 8.11.5 Bristol-Myers-Squibb Recent Developments
  67. 8.12 Aurobindo Pharma
  68. 8.12.1 Aurobindo Pharma Company Information
  69. 8.12.2 Aurobindo Pharma Business Overview
  70. 8.12.3 Aurobindo Pharma Antivirals Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aurobindo Pharma Antivirals Product Portfolio
  72. 8.12.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antivirals Value Chain Analysis
  2. 9.1.1 Antivirals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antivirals Production Mode & Process
  6. 9.2 Antivirals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antivirals Distributors
  9. 9.2.3 Antivirals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst